Sinopharm Group Co. Ltd. (SHTDY)
USD 13.79
(0.0%)
USD 13.79
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 73.78 Billion CNY | 6.02% |
| 2022 | 69.59 Billion CNY | 1.79% |
| 2021 | 68.36 Billion CNY | -0.23% |
| 2020 | 68.52 Billion CNY | 24.28% |
| 2019 | 55.13 Billion CNY | 0.06% |
| 2018 | 55.1 Billion CNY | 54.41% |
| 2017 | 35.68 Billion CNY | 6.54% |
| 2016 | 33.49 Billion CNY | 16.26% |
| 2015 | 28.81 Billion CNY | -2.18% |
| 2014 | 29.45 Billion CNY | 17.16% |
| 2013 | 25.14 Billion CNY | 56.35% |
| 2012 | 16.07 Billion CNY | 16.11% |
| 2011 | 13.84 Billion CNY | 303.17% |
| 2010 | 3.43 Billion CNY | 157.44% |
| 2009 | 1.33 Billion CNY | -18.35% |
| 2008 | 1.63 Billion CNY | -29.54% |
| 2007 | 2.31 Billion CNY | 23.23% |
| 2006 | 1.88 Billion CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 95.61 Billion CNY | 30.8% |
| 2024 Q1 | 77.25 Billion CNY | 4.71% |
| 2023 Q3 | 88.77 Billion CNY | -6.39% |
| 2023 FY | 73.78 Billion CNY | 6.02% |
| 2023 Q4 | 73.78 Billion CNY | -16.88% |
| 2023 Q2 | 94.83 Billion CNY | 30.25% |
| 2023 Q1 | 72.81 Billion CNY | 4.63% |
| 2022 Q2 | 91.9 Billion CNY | 13.09% |
| 2022 FY | 69.59 Billion CNY | 1.79% |
| 2022 Q3 | 76 Billion CNY | -17.3% |
| 2022 Q4 | 69.59 Billion CNY | -8.44% |
| 2022 Q1 | 81.26 Billion CNY | 18.87% |
| 2021 Q4 | 68.36 Billion CNY | -11.64% |
| 2021 Q1 | - CNY | -100.0% |
| 2021 Q3 | 77.37 Billion CNY | -10.85% |
| 2021 FY | 68.36 Billion CNY | -0.23% |
| 2021 Q2 | 86.78 Billion CNY | 0.0% |
| 2020 Q3 | 70.12 Billion CNY | -20.53% |
| 2020 Q2 | 88.23 Billion CNY | 42.58% |
| 2020 Q1 | 61.88 Billion CNY | 12.23% |
| 2020 FY | 68.52 Billion CNY | 24.28% |
| 2020 Q4 | 68.52 Billion CNY | -2.27% |
| 2019 Q1 | 40.16 Billion CNY | -27.11% |
| 2019 Q2 | 73.75 Billion CNY | 83.62% |
| 2019 Q3 | 50.84 Billion CNY | -31.06% |
| 2019 Q4 | 55.13 Billion CNY | 8.44% |
| 2019 FY | 55.13 Billion CNY | 0.06% |
| 2018 Q2 | 48.08 Billion CNY | 0.0% |
| 2018 Q1 | - CNY | -100.0% |
| 2018 FY | 55.1 Billion CNY | 54.41% |
| 2018 Q4 | 55.1 Billion CNY | 0.0% |
| 2017 Q3 | 37.24 Billion CNY | -14.08% |
| 2017 Q4 | 35.68 Billion CNY | -4.18% |
| 2017 FY | 35.68 Billion CNY | 6.54% |
| 2017 Q2 | 43.34 Billion CNY | 0.0% |
| 2017 Q1 | 43.34 Billion CNY | 29.4% |
| 2016 Q1 | - CNY | -100.0% |
| 2016 Q4 | 33.49 Billion CNY | 0.0% |
| 2016 Q3 | 33.49 Billion CNY | -1.86% |
| 2016 Q2 | 34.13 Billion CNY | 0.0% |
| 2016 FY | 33.49 Billion CNY | 16.26% |
| 2015 Q1 | - CNY | -100.0% |
| 2015 FY | 28.81 Billion CNY | -2.18% |
| 2015 Q3 | 28.96 Billion CNY | -8.56% |
| 2015 Q2 | 31.67 Billion CNY | 0.0% |
| 2015 Q4 | 28.81 Billion CNY | -0.52% |
| 2014 Q1 | 26.42 Billion CNY | 5.11% |
| 2014 Q4 | 29.45 Billion CNY | 0.0% |
| 2014 FY | 29.45 Billion CNY | 17.16% |
| 2014 Q3 | 29.45 Billion CNY | 11.46% |
| 2014 Q2 | 26.42 Billion CNY | 0.0% |
| 2013 Q2 | 21.65 Billion CNY | 0.0% |
| 2013 Q1 | 21.65 Billion CNY | 34.64% |
| 2013 FY | 25.14 Billion CNY | 56.35% |
| 2013 Q4 | 25.14 Billion CNY | 0.0% |
| 2013 Q3 | 25.14 Billion CNY | 16.12% |
| 2012 FY | 16.07 Billion CNY | 16.11% |
| 2012 Q2 | 14.45 Billion CNY | 0.0% |
| 2012 Q4 | 16.07 Billion CNY | 0.0% |
| 2011 FY | 13.84 Billion CNY | 303.17% |
| 2011 Q4 | 13.84 Billion CNY | 0.0% |
| 2011 Q2 | 8.08 Billion CNY | 0.0% |
| 2010 FY | 3.43 Billion CNY | 157.44% |
| 2010 Q4 | 3.43 Billion CNY | 0.0% |
| 2010 Q2 | 1.91 Billion CNY | 0.0% |
| 2009 FY | 1.33 Billion CNY | -18.35% |
| 2009 Q4 | 1.33 Billion CNY | 0.0% |
| 2009 Q2 | 2.22 Billion CNY | 0.0% |
| 2008 Q4 | 1.63 Billion CNY | 0.0% |
| 2008 FY | 1.63 Billion CNY | -29.54% |
| 2007 FY | 2.31 Billion CNY | 23.23% |
| 2006 FY | 1.88 Billion CNY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| China Medicine Corporation | 9.5 Million USD | -776047.803% |
| DH Enchantment Inc. | 412.64 Thousand USD | -17880081.075% |
| Exlites Holdings International, Inc. | - USD | -Infinity% |
| Itonis, Inc. | 910.44 Thousand USD | -8103868.516% |
| One Step Vending Corp. | 252.26 Thousand USD | -29247308.312% |
| MediPal Holdings Corporation | 9.61 Million USD | -766879.702% |
| PD-Rx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Pharmagen, Inc. | 4588.24 USD | -1608064255.831% |
| Suzuken Co., Ltd. | 11.91 Million USD | -619269.077% |